학술논문
Siremadlin, a Human Double Minute-2 (HDM2) Inhibitor, Added to Ruxolitinib after Suboptimal Response to Ruxolitinib Alone in Patients with Myelofibrosis: Results from Part 1 of the Phase 1/2 Adore Study
Document Type
Abstract
Author
Heidel, Florian H ; Perkins, Andrew Charles; Reiter, Andreas; Crodel, Carl C. ; Riley, Caroline Hasselbalch ; Gómez-Casares, María Teresa ; Takacs, Istvan ; Becker, Heiko ; Lehmann, Thomas ; Vinogradova, Olga ; Burbury, Kate ; Vannucchi, Alessandro M. ; Gupta, Vikas; Harrison, Claire; Wondergem, Marielle; Kiladjian, Jean-Jacques; Cleary, Grace ; Zhang, Angela ; Mahuzier, Bruyère ; Kota, Jagannath ; Prahallad, Anirudh ; Ross, David M
Source
In Blood 15 November 2022 140 Supplement 1:590-593
Subject
Language
ISSN
0006-4971